Coronavirus: Medical Treatments

Department of Health and Social Care written question – answered on 27th May 2022.

Alert me about debates like this

Photo of Lord Mendelsohn Lord Mendelsohn Labour

To ask Her Majesty's Government what percentage of eligible patients have received doses of COVID-19 antiviral therapies within the 5-day guidelines set out by the Joint Committee on Vaccination and Immunisation (JCVI).

Photo of Lord Kamall Lord Kamall The Parliamentary Under-Secretary for Health and Social Care

Since they were established in December 2021, COVID Medicines Delivery Units have provided antiviral or monoclonal antibody treatments to over 43,000 patients in England. Of these, over 20,100 patients have been treated with antivirals. The clinical access policies specify that the oral antivirals molnupiravir and nirmatrelvir+ritonavir must be administered within five days of the patient starting to experience symptoms. Over 95% of eligible non-hospitalised patients who have received an antiviral treatment to date were treated within five days from the onset of symptoms. However, the antiviral infusion remdesivir is suitable to be administered within seven days of the patient becoming symptomatic.

Does this answer the above question?

Yes0 people think so

No1 person thinks not

Would you like to ask a question like this yourself? Use our Freedom of Information site.